Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CNR2 anticorps (3rd Intracellular Loop)

Cet anticorps anti-CNR2 Polyclonal Lapin (ABIN7043025) détecte spécifiquement CNR2 dans WB et IHC. L’anticorps est réactif avec des échantillons de Rat.
N° du produit ABIN7043025
854,77 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 8 à 9 jours ouvrables

Aperçu rapide pour CNR2 anticorps (3rd Intracellular Loop) (ABIN7043025)

Antigène

Voir toutes CNR2 Anticorps
CNR2 (Cannabinoid Receptor 2 (CNR2))

Reactivité

  • 67
  • 28
  • 24
  • 2
  • 1
  • 1
Rat

Hôte

  • 67
  • 5
  • 1
Lapin

Clonalité

  • 68
  • 5
Polyclonal

Conjugué

  • 38
  • 7
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CNR2 est non-conjugé

Application

  • 57
  • 32
  • 30
  • 24
  • 13
  • 13
  • 10
  • 9
  • 6
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)
  • Épitope

    • 16
    • 12
    • 10
    • 8
    • 7
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    3rd Intracellular Loop, AA 228-242

    Fonction

    A Rabbit Polyclonal Antibody to Cannabinoid Receptor 2

     Réactivité croisée

    Souris, Rat

    Homologie

    Mouse - identical Human - 14 out of 15 amino acid residues identical

    Attributs du produit

    Anti-Cannabinoid Receptor 2 Antibody (ABIN7043025, ABIN7044157 and ABIN7044158) is directed against an intracellular epitope of the rat CB2 receptor. Anti-Cannabinoid Receptor 2 Antibody (ABIN7043025, ABIN7044157 and ABIN7044158) can be used in western blot and immunohistochemistry applications, and recognizes CB2 in rat samples.

    Purification

    Affinity purified on immobilized antigen.

    Immunogène

    (C)DRQVPGIARMRLDVR, corresponding to amino acid residues 228-242 of rat CB2 receptor

    Isotype

    IgG
  • Indications d'application

    WB: 1:200

    FC: The optimal concentration should be determined by the user

    ICC: The optimal concentration should be determined by the user

    IHC: 1:100-1:400

    IP: The optimal concentration should be determined by the user

    Commentaires

    Cited Application: IHC

    Negative Control: (ABIN7235032)

    Blocking Peptide: (ABIN7235032)

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    25 μL, 50 μL or 0.2 mL double distilled water (DDW), depending on the sample size.

    Concentration

    0.8 mg/mL

    Buffer

    PBS pH 7.4, 1 % BSA with 0.05 % sodium azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C
  • Antigène

    CNR2 (Cannabinoid Receptor 2 (CNR2))

    Autre désignation

    CNR2

    Sujet

    Synonyms: CB2, CNR2

    Description: Cannabinoids have been used as pain relievers in Eastern medicine for many years.1 To date, two specific cannabinoid receptors have been identified: cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2).2 The cannabinoid receptors can be distinguished by their amino acid sequence, signaling mechanisms and tissue distribution.2 Both receptors belong to the G-protein coupled receptor superfamily and are coupled to Gi/0 G protein.2,3The CB2 receptor is highly expressed in cells of the immune system such as macrophages, lymphocytes natural killer cells and mast cells but has also been shown to be expressed, by both, in situ-hybridization and in immunohistochemistry, in spleen, thymus, and pancreas.1,2,4 CB2 expression in the brain is still much less characterized than that of CB1. Recently, it was demonstrated that CB2 is expressed in the brain and might have a role in controlling fundamental processes such as proliferation and survival of neural cells.5,6Overexpression of CB2 was reported in several cancers such as prostate, glioma and acute myeloid leukemias.6 In human astrocytoma a direct relationship between CB2 expression and tumor malignancy was demonstrated. Activation of CB2 in vivo by its agonist JWH-133, completely blocked cell growth. In C6 glioma, it was shown that activation of the CB2 by JWH-133 resulted in the internalization of only the CB2 and not CB1 leading to apoptosis of the cells. This may well be a new approach for the treatment of glioma.7

    ID gène

    57302

    NCBI Accession

    NM_001841

    UniProt

    Q9QZN9
Vous êtes ici:
Chat with us!